Light Sciences Oncology Secures $6,256,000 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1c7d2dca-52c4-4c4a-8ecf-d868a503c3dc&Preview=1
Date
6/13/2011
Company Name
Light Sciences Oncology
Mailing Address
15405 SE 37th Street Bellevue, WA 98006
Company Description
Light Sciences Oncology is developing Light Infusion Therapy (Litx), an innovative light-activated treatment for solid tumors. LSO is currently developing Litx for the treatment of patients with cancers such as hepatoma, metastatic colorectal cancer and glioma, for which the current therapeutic alternatives are of limited efficacy.
Website
http://www.lsoncology.com
Transaction Type
Debt
Transaction Amount
$6,256,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. Amount may include options, warrants or other rights to acquire other securities. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed